When it comes to the ability to leverage big data, the stakes are high, according to Ashish Singh, partner and head of Global Healthcare at Bain & Company in New York City. "In the future, only companies that use real-world data to demonstrate superior outcomes for real drugs will generate attractive returns," he said.